ResearcherHarvard UniversityNo recent work listed

Christopher S. Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2445-8449; OpenAlex author ID A5100609547. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper

Papers 1

A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling. Last author DOI 10.1126/sciadv.aav6789 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Esak Lee · 1 shared paper, 2019 · strength 0.10
- Paper A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling. DOI 10.1126/sciadv.aav6789 ↗
Robert J. Norgard · 1 shared paper, 2019 · strength 0.10
- Paper A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling. DOI 10.1126/sciadv.aav6789 ↗
Duc-Huy T. Nguyen · 1 shared paper, 2019 · strength 0.10
- Paper A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling. DOI 10.1126/sciadv.aav6789 ↗
Ben Z. Stanger · 1 shared paper, 2019 · strength 0.10
- Paper A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling. DOI 10.1126/sciadv.aav6789 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.